Manning & Napier Group's GSK Position Overview
Manning & Napier Group (via Manning & Napier Advisors LLC) currently holds 1.85 M shares of GSK plc (GSK) worth $79.91 M, representing 1.02% of the portfolio. First purchased in 2024-Q2, this short-term holding has been held for 6 quarters.
Based on 13F filings, Manning & Napier Group has maintained this position in GSK for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 1.67 M shares. Largest reduction occurred in Q2 2025, reducing 16,708 shares.
Analysis based on 13F filings available since 2013 Q2
Manning & Napier Group's GSK plc (GSK) Holding Value Over Time
Track share changes against reported price movement
Quarterly GSK plc (GSK) Trades by Manning & Napier Group
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2024 | +150,001 | Add 0.00% | 150,000 | $38.50 |
| Q4 2024 | +50,000 | Add 33.33% | 200,000 | $33.82 |
| Q2 2025 | -16,708 | Reduce 8.35% | 183,292 | $38.40 |
| Q3 2025 | +1.67 M | Add 910.17% | 1.85 M | $43.16 |
Manning & Napier Group's GSK plc Investment FAQs
Manning & Napier Group first purchased GSK plc (GSK) in Q2 2024, acquiring 150,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group has held GSK plc (GSK) for 6 quarters since Q2 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group's largest addition to GSK plc (GSK) was in Q3 2025, adding 1,851,569 shares worth $79.91 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Manning & Napier Group's firm, Manning & Napier Advisors LLC, owns 1,851,569 shares of GSK plc (GSK), valued at approximately $79.91 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, GSK plc (GSK) represents approximately 1.02% of Manning & Napier Group's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group's peak holding in GSK plc (GSK) was 1,851,569 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.